Pharma Reviews: Trump's attack on pharma industry won't harm Indian generic drug makers: analysts

On an average, Indian companies are witnessing 8-9% price erosion in generics in the US, which is expected to continue in the next few years.
Read more: Trump's attack on pharma industry won't harm Indian generic drug makers: analysts